Norway· NO-ID_27B68A2E-8509-4301-B0DF-818CA10236EC
Dopram
A doxapram product containing doxapram hydrochloride, registered in Norway by Carinopharm. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Doxapram is registered in 9 of 19 countries.
Countries holding a registration under ATC R07AB01 (doxapram), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Doxapram · ATC R07AB01
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Doxapram Hydrochloride
- Manufacturer
- Carinopharm
- Country
- Norway (NO)
- ATC code
- R07AB01
- ATC class
- Doxapram
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_27B68A2E-8509-4301-B0DF-818CA10236EC
- no_varenummer34726710 x 5
- gtin4150123603186
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
66 interactions on record for doxapram.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxapram · interactions on record
66 records
- 20 severe
- 46 moderate
Most severe, free to view
- LinezolidJ01XX08severe
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxapram in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDopram
- United KingdomDopram 100mg/5ml solution for injection ampoulesMercury Pharma Group Ltd
- IrelandDoxapram Hydrochloride 20mg/ml Solution for InjectionMercuryPharm Ltd
- United StatesDopramHikma Pharmaceuticals USA Inc.
- FranceDOPRAM 2 POUR CENT, solution injectableEFISCIENS (MALTE)
- GermanyDopramCarinopharm Gmbh
- BelgiumDopram 20 mg/mlEumedica Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Belgium · Dopram
- Germany · Dopram
- France · Dopram
- United Kingdom (Northern Ireland) · Dopram, Doxapram Hydrochloride Mercury Pharmaceuticals Limited
- Ireland · Doxapram Hydrochloride Mercurypharm Ltd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efe94ff4-b401-4c7a-b46b-fe4c90f5b24a GET /v1/drugs/efe94ff4-b401-4c7a-b46b-fe4c90f5b24a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Doksapram",
"merkevare_id": "ID_27B68A2E-8509-4301-B0DF-818CA10236EC",
"name_form_strength": "Dopram inj, oppl 20 mg/ml",
"prescription_group": "C"
}See everything about doxapram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.